An eroded lesion in either the esophageal, gastric, or duodenal mucosare sulting fromt heaction of gastric secretions and typically H.pulori bacterial inflammation. For online medical resources visit at http://gisurgery.info
This document summarizes acid peptic disorders and peptic ulcer disease. It discusses the etiology, pathophysiology, clinical presentation, diagnosis, and management. The main causes of acid peptic disorders include H. pylori infection, NSAIDs, smoking, alcohol, and stress. Diagnosis involves endoscopy, testing for H. pylori, and bloodwork. Management consists of lifestyle modifications, acid suppression with PPIs or H2 blockers, H. pylori eradication therapy, and endoscopic treatment for bleeding ulcers. Surgery now has a limited role in managing peptic ulcers.
This document discusses Zollinger-Ellison syndrome, which is characterized by severe peptic ulcers caused by excessive stomach acid production due to a non-beta cell tumor known as a gastrinoma. It describes the pathophysiology, tumor distribution, clinical manifestations, diagnosis, and treatment of the condition. The gastrinoma secretes gastrin which stimulates acid secretion, potentially reaching the small intestine and inactivating pancreatic enzymes. Diagnosis involves biochemical tests and imaging to locate the tumor. Treatment options include proton pump inhibitors, somatostatin analogues, and surgery to cure the condition.
This document summarizes various acid peptic diseases. It defines acid peptic disease as a collection of diseases involving excessive acid secretion or diminished mucosal defense in the stomach and nearby gastrointestinal tract. It then briefly describes several conditions under this category including gastroesophageal reflux disease (GERD), gastritis, gastric ulcer, duodenal ulcer, esophageal ulcer, Zollinger-Ellison syndrome, and Meckel's diverticulum ulcer. For each condition, it provides details on symptoms, causes, diagnostic methods, and treatment approaches.
Chronic pancreatitis is persistent and progressive damage to the pancreas caused by chronic inflammation. The main causes are alcohol consumption (80% of cases) and gallstones. Genetic mutations and autoimmune disorders can also cause chronic pancreatitis. Patients present with epigastric pain, exocrine and endocrine insufficiency over time. Diagnosis involves imaging tests like CT, MRCP and EUS to identify structural changes and rule out other causes. Management focuses on pain relief and managing pancreatic insufficiency.
1) Inflammatory bowel disease (IBD) includes Crohn's disease and ulcerative colitis, which are chronic inflammatory disorders of the gastrointestinal tract of unknown cause.
2) Crohn's disease can affect any part of the GI tract and causes granulomatous inflammation, while ulcerative colitis causes non-granulomatous inflammation of the rectum and colon.
3) Symptoms of IBD include diarrhea, abdominal pain, rectal bleeding, weight loss, and malnutrition. Diagnostic tests include endoscopy, colonoscopy, imaging, and lab tests.
4) Treatment involves medications to reduce inflammation like aminosal
Gastroparesis is a condition in which a human stomach cannot empty itself of food in a normal manner. Gastroparesis disorder is also known as delayed gastric emptying.
Primary sclerosing cholangitis is a chronic progressive disease characterized by inflammation and fibrosis of the bile ducts. It has unknown causes but likely involves genetic and immunological factors. The disease varies in progression and can result in complications like end-stage liver disease, portal hypertension, cholangitis, or cholangiocarcinoma. While most patients with primary sclerosing cholangitis have inflammatory bowel disease, only a minority of inflammatory bowel disease patients develop primary sclerosing cholangitis. There are no proven effective treatments, so management focuses on supportive care and transplantation may be considered for complications.
This document summarizes acid peptic disorders and peptic ulcer disease. It discusses the etiology, pathophysiology, clinical presentation, diagnosis, and management. The main causes of acid peptic disorders include H. pylori infection, NSAIDs, smoking, alcohol, and stress. Diagnosis involves endoscopy, testing for H. pylori, and bloodwork. Management consists of lifestyle modifications, acid suppression with PPIs or H2 blockers, H. pylori eradication therapy, and endoscopic treatment for bleeding ulcers. Surgery now has a limited role in managing peptic ulcers.
This document discusses Zollinger-Ellison syndrome, which is characterized by severe peptic ulcers caused by excessive stomach acid production due to a non-beta cell tumor known as a gastrinoma. It describes the pathophysiology, tumor distribution, clinical manifestations, diagnosis, and treatment of the condition. The gastrinoma secretes gastrin which stimulates acid secretion, potentially reaching the small intestine and inactivating pancreatic enzymes. Diagnosis involves biochemical tests and imaging to locate the tumor. Treatment options include proton pump inhibitors, somatostatin analogues, and surgery to cure the condition.
This document summarizes various acid peptic diseases. It defines acid peptic disease as a collection of diseases involving excessive acid secretion or diminished mucosal defense in the stomach and nearby gastrointestinal tract. It then briefly describes several conditions under this category including gastroesophageal reflux disease (GERD), gastritis, gastric ulcer, duodenal ulcer, esophageal ulcer, Zollinger-Ellison syndrome, and Meckel's diverticulum ulcer. For each condition, it provides details on symptoms, causes, diagnostic methods, and treatment approaches.
Chronic pancreatitis is persistent and progressive damage to the pancreas caused by chronic inflammation. The main causes are alcohol consumption (80% of cases) and gallstones. Genetic mutations and autoimmune disorders can also cause chronic pancreatitis. Patients present with epigastric pain, exocrine and endocrine insufficiency over time. Diagnosis involves imaging tests like CT, MRCP and EUS to identify structural changes and rule out other causes. Management focuses on pain relief and managing pancreatic insufficiency.
1) Inflammatory bowel disease (IBD) includes Crohn's disease and ulcerative colitis, which are chronic inflammatory disorders of the gastrointestinal tract of unknown cause.
2) Crohn's disease can affect any part of the GI tract and causes granulomatous inflammation, while ulcerative colitis causes non-granulomatous inflammation of the rectum and colon.
3) Symptoms of IBD include diarrhea, abdominal pain, rectal bleeding, weight loss, and malnutrition. Diagnostic tests include endoscopy, colonoscopy, imaging, and lab tests.
4) Treatment involves medications to reduce inflammation like aminosal
Gastroparesis is a condition in which a human stomach cannot empty itself of food in a normal manner. Gastroparesis disorder is also known as delayed gastric emptying.
Primary sclerosing cholangitis is a chronic progressive disease characterized by inflammation and fibrosis of the bile ducts. It has unknown causes but likely involves genetic and immunological factors. The disease varies in progression and can result in complications like end-stage liver disease, portal hypertension, cholangitis, or cholangiocarcinoma. While most patients with primary sclerosing cholangitis have inflammatory bowel disease, only a minority of inflammatory bowel disease patients develop primary sclerosing cholangitis. There are no proven effective treatments, so management focuses on supportive care and transplantation may be considered for complications.
The document discusses non-alcoholic fatty liver disease (NAFLD), which includes a spectrum of conditions from simple steatosis to non-alcoholic steatohepatitis (NASH) and cirrhosis. NAFLD is strongly associated with obesity and metabolic syndrome. The prevalence of NAFLD is increasing globally and varies from 5-30% in different regions. Diagnosis requires imaging and liver biopsy. Treatment focuses on lifestyle modifications and medications to improve insulin resistance.
This document provides an overview of the approach to malabsorption syndrome. It discusses the mechanisms of malabsorption including defects that can occur in the luminal, mucosal, and post-absorptive phases. It describes specific causes of carbohydrate, protein, and fat malabsorption. Clinical manifestations can range from severe steatorrhea and weight loss to subtle changes on labs. The diagnostic approach involves considering malabsorption based on history and physical, confirming with hematological and biochemical tests, and evaluating the underlying cause with tests like imaging, endoscopy, and nutrient absorption tests.
The document provides information on inflammatory bowel disease (IBD), including its classification into ulcerative colitis and Crohn's disease. It discusses the epidemiology, etiology, pathophysiology, clinical manifestations, diagnosis, treatment goals, and pharmacological and non-pharmacological treatment approaches for IBD. The major drug therapy types used for IBD include aminosalicylates, corticosteroids, immunosuppressants, TNF inhibitors, and antimicrobials. Surgery may be required for severe cases or complications that do not respond to medical management.
This organism, formerly known as Campylobacter pylori, is now known as Helicobacter pylori, a curved bacterium that colonizes the gastric mucosa. H. pylori has been found in 90% of patients with chronic gastritis, 95% with duodenal ulcer disease, and 70% with gastric ulcer. Chronic gastritis is defined as the presence of chronic inflammatory changes in the mucosa leading to mucosal atrophy and epithelial metaplasia. The two main causes of chronic gastritis are infection by H. pylori and autoimmune gastritis. Left untreated, chronic gastritis increases the risk of peptic ulcer disease and gastric adenocarc
Acromegaly is a chronic disease caused by excessive growth hormone production, usually from a pituitary tumor, leading to enlarged hands, feet, and lower face. Gigantism is similar but occurs in childhood, resulting in excessive growth and height over 7 feet. Panhypopituitarism is decreased secretion of pituitary hormones, causing dwarfism in children and Simmond's disease in adults, characterized by multiple hormone deficiencies.
Peptic ulcer disease is caused by defects in the stomach or duodenal wall that extend through the muscularis mucosa into deeper layers. It is commonly caused by H. pylori infection or NSAID use. While complications such as bleeding or perforation once frequently required surgery, bleeding ulcers can now usually be treated nonsurgically with acid suppression medications. Maintaining intragastric pH above 6 is important for clot stabilization and ulcer healing. Proton pump inhibitors more effectively control acid secretion and maintain pH than other classes of acid suppressants.
Hyperparathyroidism can be primary, secondary, or tertiary. Primary hyperparathyroidism is usually caused by a single adenoma of the parathyroid glands and results in bone resorption and hypercalcemia. Secondary hyperparathyroidism occurs in chronic kidney disease or vitamin D deficiency as the parathyroid glands overproduce PTH in response to prolonged hypocalcemia. Tertiary hyperparathyroidism develops in some cases of longstanding secondary hyperparathyroidism as the parathyroid glands become autonomous. Radiographic findings include generalized osteopenia, brown tumors, subperiosteal bone resorption, and bone cysts. Treatment involves medication, surgery
1) Microcytic hypochromic anemia is characterized by small, pale red blood cells and can be caused by iron deficiency, thalassemia, sideroblastic anemia, or other conditions.
2) Iron deficiency anemia is the most common cause and results from inadequate iron intake or absorption. It disrupts hemoglobin synthesis and cellular proliferation.
3) Thalassemia is an inherited disorder of hemoglobin production that can range from mild to severe. Thalassemia major requires regular blood transfusions and causes severe anemia from ineffective erythropoiesis and hemolysis.
Hyperaldosteronism is a disorder in which the adrenal gland releases too much of the hormone aldosterone into the blood. Hyperaldosteronism can be primary or secondary.
The document discusses the anatomy, histology, functions and common pathologies of the liver. Key points include:
- The liver has four lobes and receives dual blood supply from the hepatic artery and portal vein. It performs many metabolic and synthetic functions.
- Common liver diseases include viral hepatitis, alcoholic liver disease and cirrhosis. Cirrhosis results from chronic liver injury and scarring that disrupts the liver architecture.
- Primary liver cancers like hepatocellular carcinoma often arise in the setting of chronic liver disease and cirrhosis. Treatment options are limited but may include transplantation or resection in early stages.
This document provides an overview of acid peptic disorders, focusing on gastroesophageal reflux disease (GERD) and peptic ulcer disease. It defines the conditions, describes their pathophysiology involving a disruption in the balance between aggressive factors like acid and protective defenses. Signs, symptoms, diagnosis, and management approaches are discussed, including lifestyle modifications, medications like PPIs, and surgery. The role of H. pylori infection in peptic ulcers and approaches to its treatment are also covered.
Ulcerative colitis and Crohn's disease are the two major types of inflammatory bowel disease. Ulcerative colitis only involves the colon while Crohn's disease can involve any part of the gastrointestinal tract. Both diseases involve chronic inflammation and can cause abdominal pain, diarrhea, and weight loss. Diagnosis involves blood tests, endoscopy, imaging, and biopsy. Treatments include medications to reduce inflammation like 5-aminosalicylates, corticosteroids, antibiotics, immunosuppressants, and biological therapies. Surgery may be required for complications or drug-resistant disease.
Celiac disease is an autoimmune condition triggered by gluten in genetically susceptible individuals. It causes inflammation in the small intestine and can have diverse multi-systemic effects. The document provides historical background on celiac disease and covers its definition, epidemiology, pathogenesis, clinical presentation, diagnosis, treatment and other aspects. Serological testing for tissue transglutaminase or endomysial antibodies is recommended for diagnosis, along with small bowel biopsy to confirm mucosal changes.
This document provides information on Cushing's syndrome, including its definition, epidemiology, causes, clinical features, investigations, treatment, and follow-up. Cushing's syndrome results from excess cortisol secretion and can be fatal if left untreated. It is rare, affecting about 2 per million people annually. The causes include pituitary adenomas (68% of cases), ectopic ACTH secretion (12%), and adrenal tumors (18%). Clinical features include weight gain, high blood pressure, and mood disturbances. Investigations involve tests to evaluate cortisol levels and distinguish ACTH-dependent from independent causes. Treatment options are surgery, radiation, medication, and adrenalectomy. Follow-up aims to detect recurrence through monitoring cortisol
This document discusses peptic ulcer disease (PUD), including its causes, types, symptoms, diagnosis, and treatment. PUD is characterized by erosion of the GI mucosa from stomach acid and pepsin. It commonly affects the lower esophagus, stomach, and duodenum. The two main types are gastric and duodenal ulcers. Symptoms include abdominal pain, nausea, and vomiting. Diagnosis involves endoscopy and tests for H. pylori bacteria. Treatment focuses on reducing stomach acid with PPIs or H2 blockers, eradicating H. pylori, and protecting the mucosa. Complications can include bleeding, perforation, and obstruction if not properly treated.
The document discusses acute and chronic pancreatitis, including causes such as alcohol abuse, gallstones, and trauma. It describes clinical features such as severe epigastric pain and elevated serum amylase and lipase levels. Diagnostic tests include blood tests, imaging like CT scans and MRCP, and endoscopic ultrasound. Treatment depends on the severity and includes IV fluids, analgesics, antibiotics, and surgery for complications like pseudocysts or obstruction.
Hypogonadism occurs when the gonads produce little or no sex hormones. There are two types: primary, where the problem is in the gonads, and secondary, where the issue is in the brain. Causes include genetic disorders, infections, tumors, and injuries. Symptoms vary between males and females but include impaired sexual development and function. Hormone tests and imaging exams diagnose and identify the cause of low hormone levels. Treatment replaces missing sex hormones through medications, supplements, or hormone therapy tailored to the individual.
This document discusses alcoholic liver disease (ALD). It notes that ALD ranges in severity from fatty liver to alcoholic hepatitis to cirrhosis. Risk factors include the amount of alcohol consumed daily and genetically. Diagnosis involves blood tests like GGT and liver biopsy. Severe alcoholic hepatitis has high short-term mortality and is treated with corticosteroids or pentoxifylline to reduce inflammation. Prognosis can be predicted using scores like Maddrey DF and management involves lifestyle changes like abstaining from alcohol and adequate nutrition.
This document discusses acid-peptic disease including lifestyle measures, pharmacological treatments, and Helicobacter pylori infection. It notes that lifestyle measures alone are generally insufficient to treat acid-peptic disease. It describes the evolution of pharmacological therapies from antacids to proton pump inhibitors (PPIs), which are the most effective initial treatment. PPIs provide rapid symptom relief and healing, even in more severe cases. The document also discusses H. pylori infection in relation to acid secretion, ulcer pathogenesis, and its role in gastroesophageal reflux disease and nonsteroidal anti-inflammatory drug ulcers. It provides recommendations for testing and treating H. pylori infection.
This document discusses drugs used for acid peptic disease. It begins by introducing acid peptic disorders and describing the imbalance between aggressive and defensive factors in the gastrointestinal tract that can lead to conditions like peptic ulcers. The document then examines the pathogenesis of these conditions and various drug therapies used to enhance defensive factors or eliminate aggressive ones. It provides detailed descriptions of different drug classes, including H2 receptor antagonists, proton pump inhibitors, anticholinergics, prostaglandin agonists, mucosal protective agents, and ulcer healing drugs. For each class, it discusses mechanisms of action, pharmacokinetics, clinical uses, and adverse effects.
The document discusses non-alcoholic fatty liver disease (NAFLD), which includes a spectrum of conditions from simple steatosis to non-alcoholic steatohepatitis (NASH) and cirrhosis. NAFLD is strongly associated with obesity and metabolic syndrome. The prevalence of NAFLD is increasing globally and varies from 5-30% in different regions. Diagnosis requires imaging and liver biopsy. Treatment focuses on lifestyle modifications and medications to improve insulin resistance.
This document provides an overview of the approach to malabsorption syndrome. It discusses the mechanisms of malabsorption including defects that can occur in the luminal, mucosal, and post-absorptive phases. It describes specific causes of carbohydrate, protein, and fat malabsorption. Clinical manifestations can range from severe steatorrhea and weight loss to subtle changes on labs. The diagnostic approach involves considering malabsorption based on history and physical, confirming with hematological and biochemical tests, and evaluating the underlying cause with tests like imaging, endoscopy, and nutrient absorption tests.
The document provides information on inflammatory bowel disease (IBD), including its classification into ulcerative colitis and Crohn's disease. It discusses the epidemiology, etiology, pathophysiology, clinical manifestations, diagnosis, treatment goals, and pharmacological and non-pharmacological treatment approaches for IBD. The major drug therapy types used for IBD include aminosalicylates, corticosteroids, immunosuppressants, TNF inhibitors, and antimicrobials. Surgery may be required for severe cases or complications that do not respond to medical management.
This organism, formerly known as Campylobacter pylori, is now known as Helicobacter pylori, a curved bacterium that colonizes the gastric mucosa. H. pylori has been found in 90% of patients with chronic gastritis, 95% with duodenal ulcer disease, and 70% with gastric ulcer. Chronic gastritis is defined as the presence of chronic inflammatory changes in the mucosa leading to mucosal atrophy and epithelial metaplasia. The two main causes of chronic gastritis are infection by H. pylori and autoimmune gastritis. Left untreated, chronic gastritis increases the risk of peptic ulcer disease and gastric adenocarc
Acromegaly is a chronic disease caused by excessive growth hormone production, usually from a pituitary tumor, leading to enlarged hands, feet, and lower face. Gigantism is similar but occurs in childhood, resulting in excessive growth and height over 7 feet. Panhypopituitarism is decreased secretion of pituitary hormones, causing dwarfism in children and Simmond's disease in adults, characterized by multiple hormone deficiencies.
Peptic ulcer disease is caused by defects in the stomach or duodenal wall that extend through the muscularis mucosa into deeper layers. It is commonly caused by H. pylori infection or NSAID use. While complications such as bleeding or perforation once frequently required surgery, bleeding ulcers can now usually be treated nonsurgically with acid suppression medications. Maintaining intragastric pH above 6 is important for clot stabilization and ulcer healing. Proton pump inhibitors more effectively control acid secretion and maintain pH than other classes of acid suppressants.
Hyperparathyroidism can be primary, secondary, or tertiary. Primary hyperparathyroidism is usually caused by a single adenoma of the parathyroid glands and results in bone resorption and hypercalcemia. Secondary hyperparathyroidism occurs in chronic kidney disease or vitamin D deficiency as the parathyroid glands overproduce PTH in response to prolonged hypocalcemia. Tertiary hyperparathyroidism develops in some cases of longstanding secondary hyperparathyroidism as the parathyroid glands become autonomous. Radiographic findings include generalized osteopenia, brown tumors, subperiosteal bone resorption, and bone cysts. Treatment involves medication, surgery
1) Microcytic hypochromic anemia is characterized by small, pale red blood cells and can be caused by iron deficiency, thalassemia, sideroblastic anemia, or other conditions.
2) Iron deficiency anemia is the most common cause and results from inadequate iron intake or absorption. It disrupts hemoglobin synthesis and cellular proliferation.
3) Thalassemia is an inherited disorder of hemoglobin production that can range from mild to severe. Thalassemia major requires regular blood transfusions and causes severe anemia from ineffective erythropoiesis and hemolysis.
Hyperaldosteronism is a disorder in which the adrenal gland releases too much of the hormone aldosterone into the blood. Hyperaldosteronism can be primary or secondary.
The document discusses the anatomy, histology, functions and common pathologies of the liver. Key points include:
- The liver has four lobes and receives dual blood supply from the hepatic artery and portal vein. It performs many metabolic and synthetic functions.
- Common liver diseases include viral hepatitis, alcoholic liver disease and cirrhosis. Cirrhosis results from chronic liver injury and scarring that disrupts the liver architecture.
- Primary liver cancers like hepatocellular carcinoma often arise in the setting of chronic liver disease and cirrhosis. Treatment options are limited but may include transplantation or resection in early stages.
This document provides an overview of acid peptic disorders, focusing on gastroesophageal reflux disease (GERD) and peptic ulcer disease. It defines the conditions, describes their pathophysiology involving a disruption in the balance between aggressive factors like acid and protective defenses. Signs, symptoms, diagnosis, and management approaches are discussed, including lifestyle modifications, medications like PPIs, and surgery. The role of H. pylori infection in peptic ulcers and approaches to its treatment are also covered.
Ulcerative colitis and Crohn's disease are the two major types of inflammatory bowel disease. Ulcerative colitis only involves the colon while Crohn's disease can involve any part of the gastrointestinal tract. Both diseases involve chronic inflammation and can cause abdominal pain, diarrhea, and weight loss. Diagnosis involves blood tests, endoscopy, imaging, and biopsy. Treatments include medications to reduce inflammation like 5-aminosalicylates, corticosteroids, antibiotics, immunosuppressants, and biological therapies. Surgery may be required for complications or drug-resistant disease.
Celiac disease is an autoimmune condition triggered by gluten in genetically susceptible individuals. It causes inflammation in the small intestine and can have diverse multi-systemic effects. The document provides historical background on celiac disease and covers its definition, epidemiology, pathogenesis, clinical presentation, diagnosis, treatment and other aspects. Serological testing for tissue transglutaminase or endomysial antibodies is recommended for diagnosis, along with small bowel biopsy to confirm mucosal changes.
This document provides information on Cushing's syndrome, including its definition, epidemiology, causes, clinical features, investigations, treatment, and follow-up. Cushing's syndrome results from excess cortisol secretion and can be fatal if left untreated. It is rare, affecting about 2 per million people annually. The causes include pituitary adenomas (68% of cases), ectopic ACTH secretion (12%), and adrenal tumors (18%). Clinical features include weight gain, high blood pressure, and mood disturbances. Investigations involve tests to evaluate cortisol levels and distinguish ACTH-dependent from independent causes. Treatment options are surgery, radiation, medication, and adrenalectomy. Follow-up aims to detect recurrence through monitoring cortisol
This document discusses peptic ulcer disease (PUD), including its causes, types, symptoms, diagnosis, and treatment. PUD is characterized by erosion of the GI mucosa from stomach acid and pepsin. It commonly affects the lower esophagus, stomach, and duodenum. The two main types are gastric and duodenal ulcers. Symptoms include abdominal pain, nausea, and vomiting. Diagnosis involves endoscopy and tests for H. pylori bacteria. Treatment focuses on reducing stomach acid with PPIs or H2 blockers, eradicating H. pylori, and protecting the mucosa. Complications can include bleeding, perforation, and obstruction if not properly treated.
The document discusses acute and chronic pancreatitis, including causes such as alcohol abuse, gallstones, and trauma. It describes clinical features such as severe epigastric pain and elevated serum amylase and lipase levels. Diagnostic tests include blood tests, imaging like CT scans and MRCP, and endoscopic ultrasound. Treatment depends on the severity and includes IV fluids, analgesics, antibiotics, and surgery for complications like pseudocysts or obstruction.
Hypogonadism occurs when the gonads produce little or no sex hormones. There are two types: primary, where the problem is in the gonads, and secondary, where the issue is in the brain. Causes include genetic disorders, infections, tumors, and injuries. Symptoms vary between males and females but include impaired sexual development and function. Hormone tests and imaging exams diagnose and identify the cause of low hormone levels. Treatment replaces missing sex hormones through medications, supplements, or hormone therapy tailored to the individual.
This document discusses alcoholic liver disease (ALD). It notes that ALD ranges in severity from fatty liver to alcoholic hepatitis to cirrhosis. Risk factors include the amount of alcohol consumed daily and genetically. Diagnosis involves blood tests like GGT and liver biopsy. Severe alcoholic hepatitis has high short-term mortality and is treated with corticosteroids or pentoxifylline to reduce inflammation. Prognosis can be predicted using scores like Maddrey DF and management involves lifestyle changes like abstaining from alcohol and adequate nutrition.
This document discusses acid-peptic disease including lifestyle measures, pharmacological treatments, and Helicobacter pylori infection. It notes that lifestyle measures alone are generally insufficient to treat acid-peptic disease. It describes the evolution of pharmacological therapies from antacids to proton pump inhibitors (PPIs), which are the most effective initial treatment. PPIs provide rapid symptom relief and healing, even in more severe cases. The document also discusses H. pylori infection in relation to acid secretion, ulcer pathogenesis, and its role in gastroesophageal reflux disease and nonsteroidal anti-inflammatory drug ulcers. It provides recommendations for testing and treating H. pylori infection.
This document discusses drugs used for acid peptic disease. It begins by introducing acid peptic disorders and describing the imbalance between aggressive and defensive factors in the gastrointestinal tract that can lead to conditions like peptic ulcers. The document then examines the pathogenesis of these conditions and various drug therapies used to enhance defensive factors or eliminate aggressive ones. It provides detailed descriptions of different drug classes, including H2 receptor antagonists, proton pump inhibitors, anticholinergics, prostaglandin agonists, mucosal protective agents, and ulcer healing drugs. For each class, it discusses mechanisms of action, pharmacokinetics, clinical uses, and adverse effects.
Acid peptic disorders include gastroesophageal reflux disease (GERD) and peptic ulcer disease. GERD is defined as chronic symptoms or mucosal damage caused by abnormal reflux of gastric contents into the esophagus. Peptic ulcers are defects in the gastrointestinal mucosa that extend through the muscularis mucosa. Common causes of peptic ulcers include Helicobacter pylori infection and NSAID use. Treatment involves eradicating H. pylori, discontinuing NSAIDs, and using proton pump inhibitors, H2 receptor antagonists, or prostaglandins to promote healing.
This document summarizes the treatment of acid peptic disease using various drug classes. It discusses proton pump inhibitors, H2 receptor blockers like cimetidine and ranitidine, antacids, mucosal protectants, and more. Specific drugs are listed along with their mechanisms of action, pharmacokinetics, therapeutic uses, preparations and doses, and potential adverse effects. A comparison is provided between cimetidine and ranitidine.
This document discusses peptic ulcer disease (PUD), including risk factors, pathophysiology, diagnosis, and treatment. Some key points:
- H. pylori infection and NSAID use are the leading causes of PUD. H. pylori infection is present in 60% of Americans over age 60.
- Diagnosis involves testing for H. pylori (stool antigen, urea breath, serology), and endoscopy if high risk or symptoms persist after treatment.
- Treatment for H. pylori-associated PUD is triple therapy (PPI plus two antibiotics) for 14 days. NSAID-associated PUD is treated with PPIs and prostag
Peptic ulcer disease is caused by gastric or duodenal ulcers that form lesions in the stomach or duodenal mucosa. Risk factors include H. pylori infection, smoking, NSAID use, and genetic factors. Symptoms include epigastric pain relieved by food and antacids. Treatment aims to relieve pain, eradicate H. pylori infection, heal ulcers, and prevent recurrence through lifestyle changes and medication like PPIs or H2 blockers. Surgery was more common historically but is now rare due to H. pylori treatments, though it may be used for complications like perforation.
Peptic ulcer disease is caused by an imbalance between acid-pepsin secretion and mucosal defense. Major causes include Helicobacter pylori infection, NSAID use, and smoking. Common symptoms are epigastric pain, vomiting, and bleeding. Diagnosis involves endoscopy and biopsy to detect ulcers and test for H. pylori. Treatment involves acid suppression, antibiotics to eradicate H. pylori, and surgery for complications like perforation or bleeding. Goals of treatment are pain relief, H. pylori eradication, ulcer healing, and prevention of recurrence.
Acid peptic disease includes conditions like acid reflux and ulcers that are caused by excess stomach acid. Dr. Nasir Khokhar, a professor of medicine and director of gastroenterology at Shifa International Hospital in Islamabad, Pakistan, gave an update on acid peptic disease. He thanked attendees for their attention.
Acid peptic disease /certified fixed orthodontic courses by Indian dental aca...Indian dental academy
Welcome to Indian Dental Academy
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and offering a wide range of dental certified courses in different formats.
Indian dental academy has a unique training program & curriculum that provides students with exceptional clinical skills and enabling them to return to their office with high level confidence and start treating patients
State of the art comprehensive training-Faculty of world wide repute &Very affordable.
Peptic ulcer disease is caused by an imbalance between aggressive and defensive factors in the stomach and duodenum. The two most common causes are Helicobacter pylori infection, present in 70-80% of cases, and use of non-steroidal anti-inflammatory drugs. H. pylori infection triggers chronic inflammation and increases acid production, while NSAIDs inhibit protective prostaglandins. Stress, smoking, alcohol and certain medical conditions can also contribute to ulcer development by further disrupting the mucosal barrier. Peptic ulcers may be acute, caused by severe injury or illness, or chronic.
Peptic ulcer disease and GERD are common digestive disorders caused by an imbalance between gastric acid and the stomach's protective mechanisms. Peptic ulcers form when the stomach or duodenal lining is broken down, typically due to H. pylori infection or long-term NSAID use. GERD occurs when stomach acid backs up into the esophagus, often due to a weak lower esophageal sphincter. Both are treated using proton pump inhibitors to reduce acid production along with antibiotics for H. pylori if present. Lifestyle changes like sleeping upright and smaller meals can help prevent acid reflux.
Peptic ulcer (defination, cause, tratment)Mohd Mohd
This document summarizes peptic ulcer disease and acid peptic disorders. It discusses the anatomy of the stomach, risk factors for peptic ulcers, symptoms, physiology of acid secretion, and treatments. The main causes of peptic ulcers are Helicobacter pylori infection and NSAID use. Treatment involves acid suppression with proton pump inhibitors or H2 blockers, eradicating H. pylori infections, and mucosal protective agents.
The document discusses acid peptic disorders and treatments such as proton pump inhibitors (PPIs). It notes that while all PPIs are generally effective, they differ in properties like onset of action and ability to control symptoms rapidly. Rabeprazole is highlighted as a PPI that may have advantages over others due to its faster onset of activity from more rapid activation rates, potentially providing quicker symptom relief. Clinical studies demonstrate rabeprazole's effectiveness in treating gastroesophageal reflux disease.
Peptic Ulcer Disease Affects All Age Groups. Can occur in children, although rare. Duodenal ulcers tends to occur first at around the age 25 and continue until the age of 75. Gastric ulcers peak in people between the ages of 55 and 65. Men Have Twice The Risk as Women Do
Peptic ulcer disease is defined as an ulcer occurring in areas exposed to gastric acid and pepsin, most commonly the duodenum or stomach. Key risk factors include infection with Helicobacter pylori bacteria and use of non-steroidal anti-inflammatory drugs. Patients may experience abdominal pain relieved by food or antacids, though physical exams are often unremarkable. Complications can include bleeding, perforation, or scarring. Diagnosis involves endoscopy, biopsy, and tests for H. pylori infection.
The document discusses drugs used to treat peptic ulcers, gastroesophageal reflux disease, diarrhea, and constipation. It describes the causes of peptic ulcers including H. pylori infection and NSAID use. Treatment involves eradicating H. pylori, reducing gastric acid with H2 blockers or proton pump inhibitors, and protecting the gastric mucosa. Various classes of drugs are covered that act on these mechanisms including antimicrobials, H2 blockers, proton pump inhibitors, prostaglandins, and antacids.
Peptic ulcer disease involves breaks in the mucosal lining of the stomach or duodenum that penetrate through the muscular layer. The most common causes are infection with H. pylori bacteria and use of non-steroidal anti-inflammatory drugs (NSAIDs). Symptoms include abdominal pain, nausea, and weight loss. Diagnosis involves endoscopy to visualize the ulcers. Treatment involves antibiotics to eradicate H. pylori, proton pump inhibitors to reduce acid secretion, and avoidance of NSAIDs. Surgery is reserved for complications or treatment failure.
The document discusses various drugs that affect the gastrointestinal system. It reviews drugs that affect GI secretions like histamine H2 receptor blockers, antacids, proton pump inhibitors, mucosal protectants, and prostaglandin analogs. It then focuses on H2 blockers, antacids, proton pump inhibitors, the mucosal protectant sucralfate, and the prostaglandin analog misoprostol, describing their mechanisms of action, clinical uses, precautions, side effects, and drug interactions. The document also briefly mentions the therapeutic indications of laxatives.
This document discusses the pharmacotherapy of peptic ulcers. It begins by classifying the main drugs used: 1) those that inhibit gastric acid secretion like H2 blockers and proton pump inhibitors, 2) antacids that neutralize acid, 3) ulcer protectives like sucralfate, and 4) anti-H. pylori drugs for eradication. It then goes into detail about the mechanisms, uses, and side effects of the major drug classes. H2 blockers competitively block H2 receptors to suppress acid secretion. Proton pump inhibitors irreversibly inactivate the H+/K+ ATPase pump for prolonged acid inhibition. Antacids chemically neutralize acid. Sucralfate
The document discusses peptic ulcers, which are sores in the lining of the stomach or duodenum caused by an imbalance between defensive and damaging factors. Key points include: Helicobacter pylori bacteria and NSAIDs are major causes of ulcers. Symptoms include abdominal pain relieved by food or antacids. Complications can include bleeding, perforation, or obstruction if not treated. Treatment involves antibiotics to eliminate H. pylori, acid reducers to promote healing, and lifestyle changes like quitting smoking.
The gastrointestinal tract is the tract or passageway of the digestive system that leads from the mouth to the anus.
GI tract is a series of hollow organs joined in a long, twisting tube from the mouth to the anus.
The hollow organs that make up the GI tract are mouth, esophagus, stomach, small intestine, large intestine and anus.
The GI tract contains all the major organs of the digestive system, in humans and other animals.
Digestive disorders are among the most common problems in health care.
Approximately 30-40% adults claim to have frequent indigestion.
Indigestion
Peptic ulcer
Carcinoma of the Stomach
Gastric Surgery
Dumping Syndrome
Constipation
Diarrohoea
Steatorrhoea
Lactose Intolerance
Coeliac Disease
Tropical sprue
Irritable Bowel Syndrome
Inflammatory Bowel Diseases
Intestinal Gas and Flatulence
Diverticular Disease
Indigestion also called dyspepsia which means discomfort in the upper digestive tract.
Indigestion can be caused by dietary indulgences-excessive volumes of food or high intake of fat, sugar, caffeine, spices or alcohol or both.
Symptoms : vague abdominal pain
Bloating
Nausea
Regurgitation and belching
If it is prolonged it can lead to gastro-oesophagul reflux, gastritis, peptic ulcer disease, delayed gastric emptying, gall bladder disease or cancer.
It can be treated by eating slowly, chewing thoroughly and not eating or drinking excessively.
Localized erosion of the mucosal lining of those portions of the alimentary tract that come in contact with the gastric juice.
This disintegration of tissues can also result in necrosis.
Ulcers occurs in oesophagus, stomach, jejunum and duodenum but majority of ulcers are found in the duodenum.
All the ulcers have same symptoms and same response to treatment regardless of location.
Mechanism of ulcer formation
Three vital mechanisms are the mucus layer, prostaglandins and probably the urogastrone /epidermal healing factor(URO/EHF).
These mechanisms can protect the stomach against HCL up to twice the maximum concentration which the stomach is capable of secreting.
The mucous layer, viscous gel is ideally suited for its function of protection from chemical and physical hazards of water proofing and lubrication.
The second line of defence are prostaglandins.
Third line of defence that is urogastrone plays important role by inhibiting gastric acid secretion and by stimulation of cell proliferation and regeneration for healing the ulcer.
If mucosal line is broken then underlying layers of the stomach are exposed to the effect of concentrated acid which results in peptic ulcer.
Duodenal Ulcer :
Peptic ulcer that develops in first part of the small intestine.
Hypersecretion of acid
Tissue resistance is normal
Acid hypersecretion is due to increased number of parietal cells and impaired rapid gastric emptying with loss of buffering effect.
Excess production of acid and pepsin is the primary factor.
Gastric Ulcer
Peptic ulcer disease is caused by defects in the stomach or duodenal lining from gastric acid and pepsin. Common causes include H. pylori infection, NSAID use, smoking, and stress. Patients may experience burning epigastric pain or develop complications like bleeding. Diagnosis involves endoscopy with biopsy or urea breath testing. Treatment aims to relieve symptoms, heal ulcers, and prevent recurrence with medications like PPIs, antibiotics, and lifestyle changes. Patients are advised to avoid irritants, eat small frequent meals, and see a doctor immediately if they experience signs of bleeding.
This document discusses peptic ulcer disease (PUD), including its definition, epidemiology, etiology, symptoms, investigation, and treatment. PUD is caused by acid and pepsin digestion of the stomach or duodenal lining. Key contributing factors include Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use. Common symptoms are abdominal pain and vomiting. Diagnosis involves endoscopy with biopsy and testing. Treatment aims to relieve symptoms, promote healing, and eradicate H. pylori if present through medications like PPIs, H2 blockers, and antibiotic combinations.
The document discusses the anatomy, functions, digestion and role of bacteria in the large intestine. It also summarizes ulcerative colitis, Crohn's disease and constipation by comparing their symptoms, diagnosis, causes and common treatments. Key biochemical parameters for diagnosing intestinal disorders are outlined. The importance of nutritional management for conditions like Crohn's disease, ulcerative colitis and constipation is highlighted. A case study treatment plan for Crohn's disease focuses on achieving goals like weight gain, normalizing stool and managing gastrointestinal complaints through an enriched diet and supplementation.
This document discusses the dietary management of various gastrointestinal diseases including diarrhea, constipation, gastritis, and peptic ulcers. It describes the anatomy and functions of the digestive system. It defines different types of constipation and diarrhea and their causes. Dietary recommendations are provided for different GI conditions, focusing on fluid and fiber intake, meal patterns, and avoiding irritating foods. Medical treatments including drugs and H. pylori eradication therapies are also summarized.
Gastritis is an inflammation of the stomach lining that can be either acute or chronic. Acute gastritis is short-term and caused by factors like NSAIDs, alcohol, bile reflux, or radiation/chemotherapy. Chronic gastritis is long-term inflammation that can result from repeated acute episodes or be caused by H. pylori bacteria or chemical irritants. Symptoms include epigastric pain, nausea, vomiting, and bleeding. Treatment involves antacids, H2 blockers, PPIs, and antibiotics for H. pylori. Nursing care focuses on pain relief, nutrition, fluid balance, education, and symptom management.
This presentation is to help readers to be equipped with knowledge on predisposing factor to peptic ulcer disease and how it can be managed in the clinical/hospital setup.
This document discusses nutritional therapy for various gastrointestinal tract disorders. It describes disorders that affect the upper GI tract such as esophagitis, hiatal hernia, and stomach issues like gastritis and peptic ulcers. Nutritional recommendations include avoiding acidic, spicy, or fatty foods. Lower GI disorders mentioned include intestinal gas, constipation, diarrhea, and celiac disease. Nutritional care focuses on replenishing electrolytes during diarrhea and excluding gluten for celiac disease. The document provides details on various GI conditions and their corresponding nutritional treatment plans.
This document discusses nutritional care in cancer patients. It notes that malnutrition leads to increased morbidity, mortality and decreased quality of life. Up to 20% of cancer patients die from nutritional complications rather than their primary disease. Cancer and cancer therapies can cause anorexia, cachexia, and metabolic changes that negatively impact nutrition. Nutritional assessment and interventions are important for cancer patients to prevent deficiencies and weight loss.
Ulcerative collitis, Nutritional needs and medical nutrition therapy MNThawa mushtaq
Ulcerative colitis is an inflammatory bowel disease that causes long-lasting inflammation and ulcers in the digestive tract. It affects the innermost lining of the large intestine and rectum. Symptoms include diarrhea, abdominal pain, rectal bleeding, and weight loss. Nutritional deficiencies can occur due to reduced intake, absorption issues, and increased losses. A comprehensive nutrition plan is important to improve symptoms and quality of life by addressing deficiencies, managing diet during flares and remission, and recommending foods and nutrients to support healing.
This document discusses various gastrointestinal disturbances and their corresponding therapeutic diets. It begins by outlining objectives of diet therapy for GI issues and identifying allowed/restricted foods. Examples of mouth problems addressed with soft, non-acidic foods are provided. Conditions like peptic ulcers, diverticulosis, inflammatory bowel disease, celiac disease, cirrhosis and hepatitis are examined alongside their recommended nutrition therapies. Both high-fiber and low-fiber diets are defined in terms of their fiber contents and appropriate uses.
This document provides information about peptic ulcer disease (PUD) and its treatment with Omeprazole. PUD is caused by an imbalance between gastric acid and the stomach's protective mechanisms. Helicobacter pylori infection is responsible for most cases of PUD. Omeprazole is a proton pump inhibitor that suppresses gastric acid production by inhibiting the hydrogen-potassium ATPase enzyme in parietal cells. It has high bioavailability, is well-tolerated though some patients report side effects like headache and diarrhea. Omeprazole is effective for treating PUD and in combination with antibiotics can help eradicate H. pylori infections. It provides effective relief of symptoms from conditions
A therapeutic diet is a meal plan prescribed to treat a medical condition. It controls certain foods/nutrients and is planned by a dietician under physician guidance. Therapeutic diets aim to maintain good nutrition, correct deficiencies, adjust food intake based on ability to metabolize nutrients, and change body weight if needed. Modifications can be qualitative like restricting/excess of nutrients, or quantitative like changing consistency or meal frequency/composition. Common hospital diets include clear liquids, full fluids, soft foods, and normal diets for various indications.
P. Kolala presented on peptic ulcer disease. PUD is caused by an imbalance between gastric acid production and mucosal defenses, resulting in ulcers in the esophagus, stomach, or duodenum. Risk factors include H. pylori infection, NSAID use, smoking, and stress. Symptoms include epigastric pain relieved by food or antacids. Treatment involves eradicating H. pylori with antibiotics, reducing acid with PPIs, and surgery if complications occur or medications fail. Nursing care focuses on pain management, diet, medication administration and monitoring for complications.
This document discusses drugs used to treat constipation. It begins by defining constipation and describing its common causes and symptoms. It then classifies laxatives and describes the mechanisms of different laxative types, including bulk-forming agents, stool softeners, osmotic purgatives, and stimulant purgatives. The document provides examples of specific drugs for each laxative class and their dosages. It concludes by discussing the appropriate choice and use of laxatives as well as the risks of laxative abuse.
Constipation is a common complaint defined as infrequent bowel movements and difficult bowel movements. The Rome III criteria are used to diagnose chronic constipation. Constipation can be primary/functional with no clear cause or secondary due to causes like immobility, diet, medical conditions, or medications. Management involves lifestyle changes and laxatives. Laxatives are classified as bulk forming, stool softeners, stimulant purgatives, or osmotic purgatives. Bulk forming laxatives like bran and psyllium work by increasing stool bulk while osmotic laxatives like lactulose work by retaining fluid in the intestines. Diarrhea is defined as 3 or more loose stools per day and can
This document provides an overview of diet therapy for various diseases and surgical conditions. It discusses indications, contraindications and clinical implications of different diet types (e.g. clear liquid, full liquid, pureed) for diseases like diarrhea, constipation, peptic ulcers, and conditions requiring surgery of the mouth, throat, esophagus or gastrointestinal tract. Specific postoperative diets are outlined for surgeries like gastrectomy, intestinal surgery and cholecystectomy.
Why does your doctor recommend you to have more fruits, vegetables and cereals when you're having constipation? Why is it good to have fiber? Why are Cardio Vascular Diseases on a rise? This presentation tells it all and highlights how it is related to Dietary Fiber...
Short bowel syndrome (SBS) occurs when extensive segments of the small intestine are resected, severely compromising absorptive capacity. It is a leading cause of intestinal failure in infants, with an incidence of 0.1-0.5% among live births and ICU admissions. The minimal length of small intestine needed to survive is 15-38 cm, though adaptation allows survival with even shorter lengths. Management involves total parenteral nutrition, optimizing enteral nutrition, and treating complications until the remnant intestine sufficiently adapts through processes like increased blood flow and growth. With current treatment, 80% of infants with SBS achieve full enteral nutrition within a year.
1) Diarrheal diseases are a major cause of mortality and morbidity in children worldwide, especially in developing countries, with nearly 1.5 million children dying from acute diarrhea in India alone each year.
2) The causes of diarrhea in children include viral, bacterial, and protozoal infections transmitted through contaminated food and water, as well as non-infectious causes like malnutrition and inflammatory bowel diseases.
3) Treatment of diarrhea involves oral rehydration with solutions like ORS to correct fluid and electrolyte imbalances, continued feeding, and potentially antibiotics for bacterial causes or zinc supplementation.
Component separation technique for a very large abdominal wall herniaSanjiv Haribhakti
Component separation technique is an excellent technique for large ventral central defects which can allow a medial shift of approx. For More information visit at Gisurgery.info
Understant what is obesity and Bariatric Surgery, what are the risk factors and how to overcome on the it. For more information visit at http://gisurgery.info
The document discusses the effects of aging on the digestive system. It states that as people age, the esophagus and stomach are less able to contract strongly and accommodate large amounts of food. Absorption in the small intestine changes little with age, but lactase production decreases, causing lactose intolerance. The liver shows some functional decline with aging as well. The document provides details on specific changes that occur in different parts of the digestive system as people get older.
Lifestyle Diseases are diseases that are caused partly by unhealthy behaviors and partly by other factors. "Lifestyle-Related" Diseases are now the leading cause of death worldwide. To get tips to active lifestyle, visit at http://gisurgery.info
This document discusses the importance of exercise for overall health and different body systems. It recommends starting with aerobic exercises like walking, jogging, swimming or dancing. Exercise provides benefits like improved flexibility, heart and lung function, and prevention of issues like fat deposition or circulatory diseases. While some people make excuses to not exercise, the document encourages setting small, achievable goals and finding types of exercise you enjoy to build a regular routine.
Intestinal obstruction or bowel obstruction is a partial or complete blockage of the intestine or bowel that prevents intestinal content from passing through. To know Symptoms, Causes and Treatment of Intestinal Obstruction, visit at http://gisurgery.info
Gallbladder is a small organ located under the liver. Its function is to aid in digestion of food by storing and secreting bile (a digestive juice) into the small intestine when food enters there. Gallstone Disease may develop when there is too much cholesterol or bilirubin inside gallbladder secreted by the liver. To know the signs & symptoms of Gallstone Disease. visit at http://gisurgery.info
Common Bile Duct (CBD) is a tube that carries bile from gallbladder or liver to the small intestine. Gallstone may develop when there is too much cholesterol or bilirubin inside gallbladder secreted by the liver. CBD stones may not have any signs & symptoms for months or even years. However, if the blockage becomes severe, then some signs & symptoms may be experienced. For more information, visit at http://gisurgery.info
Did you know that your core is where all movement in your body originates? Core exercises are an important part of overall fitness training that, except for the occasional sut-up or crunch are often neglected. For more health Tips, Visit at http://gisurgery.info
Osteoporosis is a condition characterized by a decrease in the density of bone, decreasing its strength and resulting in fragile bones. Know the Risk Factors for Osteoporotic Fracture, Preventive Measures and exercise for osteoporosis. For more health Tips, Visit at http://gisurgery.info
Practicing good posture can make a big different in your health, well-being, mood and your appearance. Learn More how Good posture affects both your physical body as well as your emotional and mental well-being. For more health Tips, Visit at http://gisurgery.info
Vertebral Column is a complex structure of the Human body. It does not only provides protection for spinal cord but also provide mobility and stability of the trunk and the extremities. To learn structure of Vertebral Column and more Online Medical Resource, Visit at http://gisurgery.info
MUSCLES OF THE VERTEBRAL COLUMN- The system of ligaments in the vertebral column, combined with the tendons and muscles, provides a natural brace to help protect the spine from injury. For More Online Medical Resource, Visit at http://gisurgery.info
It is a metabolic disorder characterized by decreased ability or total in ability of the tissues to utilize CHO(glucose). This results in shifts and disturbances in the fat and protein metabolism and in water and electrolyte balance. This disorder is due to absence to insulin, its deficiency or ineffectiveness – the hormone is produced by the beta cells of islet of langerhans in the pancreas. For More health tips visit at http://gisurgery.info/player_presentation.php?id=87
Food Group Pyramid - According to RDA, average calorie consumption for human body is around 2000 kcal/day. Learn how can you make the balanced diet choices for you which will help you stay healty. The Food pyramid will help you choose what and how much to eat from each food group. For more health tips, visit at Gisurgery.info
Learn classification of blood pressure and stages of hypertasion in adults. To know reason and complecations of hypertension, visit at http://gisurgery.info/player_presentation.php?id=90
What is Indigestion? Sensation of fullness or heaviness or discomfort in upper abdomen. Indigestion
may include Heartburn, upper abdominal pain, Bloating, Feeling of distension and Nausea. Know more about Indigestion prevention visit :- http://gisurgery.info/player_presentation.php?id=125
Lifestyle changes can prevent at least 60% of all Cancers - By Dr Sanjiv Hari...Sanjiv Haribhakti
5–10% of all cancer cases can be attributed to genetic defects, whereas the remaining 90–95% have their roots in the environment and lifestyle factors. Learn how can we prevent lifestyle related cancers. For more details visit at http://gisurgery.info
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
2. An eroded lesion in either the esophageal, gastric, or duodenal
mucosa resulting from the action of gastric secretions and typically
H.pulori bacterial inflammation.
3. • Normal gastric and duodenal mucosa is protected from the digestive
actions of acid and pepsin by the secretion of mucus, the production of
bicarbonate, the removal of excess acid by normal blood flow, and the
rapid renewal and repair of epithelial cell injury.
• Peptic ulcer refers to an ulcer that occurs as a result of the breakdown
of these normal defense and repair mechanisms.
• Typically more than one of the mechanisms must be malfunctioning
for symptomatic peptic ulcer to develop.
• Peptic ulcer typically show evidence of chronic inflammation and
repair processes surrounding the lesion.
4. Acid peptic ulcer may develop due to any of the following reasons.
• H.pylori infection.
• Increased number of parietal cell or acid secretion.
• Increased gastric emptying rates.
• Reduced ability of the duodenum to handle an acid load.
• Stress
• Excessive use of non steroidal anti inflammatory drugs (NSAID) and
corticosteroids.
5. • Increased gastric tone and painful hunger contraction when stomach
is empty.
•Piercing, burning and gnawing pain which usually relieved by taking
food.
• Frequent vomiting sometimes with blood too.
• Anorexia
6. • Gastrointestinal bleeding
• Intestinal perforation
•Peritonitis (inflammation of the lining of abdominal cavity)
• Anemia
• Intestinal narrowing and obstruction
• Shock
7. • Restoration of good nutritional status with dietary modifications
and counseling.
• Alleviate the symptoms.
• Neutralize acids.
• Reduce acid secretion.
• Preservation of epithelial resistance to the destructive action of
gastric juices.
8. • Milk neutralizes gastric acidity only for 20 to 60 minutes after its
ingestion and the PH reverts back to the basal levels. Current studies
indicate that a diet with high milk content has an adverse effect on the
healing rate of ulcer because of high calcium. So protein from cottage
cheese, egg, chicken and fish in adequate amounts is beneficial for
regeneration of cell. Additional protein 10-15g/day above the RDA can be
given.
• The products of fat digestion in the small intestine stimulate
entrogastrone, which inhibits gastric juice secretion. PUFA such as linoleic
and eicosapentanoic acid have been found to effective against duodenal
ulcer by inhibiting in vitro growth of H.Pylori. Around 25-30 g visible fat in
emulsified form can be given. Avoid fried foods as they cause digestive
problems.
9. • 55 to 65% of CHO can be given in simple and complex form but in
soft well cooked form. Soluble fiber is more beneficial than insoluble
as insoluble fiber delays gastric emptying time hence prevents the
mucosal damage by acidic gastric juice.
• Fruits in general are related to an alkaline ash diet. If they are not
well tolerated by some individuals, avoid them.
• Avoid taking alcohol, caffeine, black pepper ad meat extracts as
they significantly change gastric pH.
• Clinical observations have shown that tolerance for a variety of
standard foods is highly individual. Pulse, soyabean, cabbage,
cauliflower, onions, peas, apple, watermelon are some of the foods
identified.
10. • Cigarette smoking cause an adverse effect because of the presence of
nicotine which cause pyloric incompetence, increased reflux of
duodenal juice into the stomach, increased gastric acid secretion by
favoring gastric secretion, decrease pancreatic bicarbonate synthesis.
11. Stage 1
• Initially, for bleeding ulcer, if the patient is extremely nauseated or
vomiting he must be kept NBM
• This is followed by an hourly feeding to begin with milk and cream
100g/hr followed by small feeding of easily digestible food like soft
cooked eggs, custards, refined flour products, cottage cheese, low
fiber vegetables like gourds, clear soup with no seasoning and herbs,
soft over ripe fruit whips and light desserts.
• The diet must be feed orally and of liquid/semi liquid/ soft
consistency which is easy to digest
12. Stage 2
• Marked recovery from pain.
• 6 meal pattern followed.
• Light, blend, low fiber diet.
• Mechanical/ thermal, chemical irritation of gastric mucosa to be
avoided.
•Late night feeding avoided as the end products of digestion may
cause the epigastric pain.
13. Stage 3
• Number of feeds reduced to 3-4.
• Discharged from hospital – discharged diet
• Increased amount/ feed
Stage 4
• Liberalizing the diet depending on the patient’s individual
tolerance and schedule.
• Ensuring optimum intake of calorie, protein, fats, vitamins and
minerals.
•Relaxed atmosphere on eating.
• Lifestyle change.